Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gall

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patientsA Baars, A M Claessen, A J van den Eertwegh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Phase I trial with BMS-275183, a novel oral taxane with promising antitumor activityLinda E Bröker, Filip Y F L de Vos, Cees J van Groeningen, et al.
Cell|May 20, 2009
Protein architecture of the human kinetochore microtubule attachment siteXiaohu Wan, Ryan P O'Quinn, Heather L Pierce, et al.
Plos One|November 19, 2010
Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological settingKarsten Suhre, Christa Meisinger, Angela Döring, et al.
British Journal of Cancer|April 16, 2002
A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinomaA Baars, A M E Claessen, J Wagstaff, et al.
Diabetes|February 5, 2013
Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetesWeijia Xie, Andrew R Wood, Valeriya Lyssenko, et al.
The Lancet. Oncology|February 14, 2012
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialAlfons J M van den Eertwegh, Jurjen Versluis, H Pieter van den Berg, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patientsA Baars, A M Claessen, A J van den Eertwegh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Phase I trial with BMS-275183, a novel oral taxane with promising antitumor activityLinda E Bröker, Filip Y F L de Vos, Cees J van Groeningen, et al.
Cell|May 20, 2009
Protein architecture of the human kinetochore microtubule attachment siteXiaohu Wan, Ryan P O'Quinn, Heather L Pierce, et al.
Plos One|November 19, 2010
Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological settingKarsten Suhre, Christa Meisinger, Angela Döring, et al.
British Journal of Cancer|April 16, 2002
A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinomaA Baars, A M E Claessen, J Wagstaff, et al.
Diabetes|February 5, 2013
Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetesWeijia Xie, Andrew R Wood, Valeriya Lyssenko, et al.
The Lancet. Oncology|February 14, 2012
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialAlfons J M van den Eertwegh, Jurjen Versluis, H Pieter van den Berg, et al.
Pageof 7